Optimization of important early ADME(T) parameters of NADPH oxidase-4 inhibitor molecules
Through their reactive oxygen species (ROS) producing function, NADPH oxidase (NOX) enzymes have been linked to several oxidative stress related diseases. In our recently published paper [1] we have already shown the NOX4 inhibitory effect of diverse, molecule sub-libraries and their biological importance. We also presented our work connected to potential anti-tumour molecules and the relationship between their biological activity and physico-chemical properties [2]. As an extension of these studies further physico-chemical and biological investigation has been carried out on a molecule group included NOX4 inhibitory chromanone compounds. Here we describe the optimization of early ADME(T) parameters determining lipophilicity, phospholipophilicity and permeability linked to structure-activity relationship. We prove that optimal lipo- and phospholipophilicty can be also determined in case of NOX4 inhibitors and a comparison will be made between the chemically similar isochromanone and chromanone molecular libraries. It will be also shown how to predict the effect of different substituents on permeability, lipo- and phospholipophilicity and also the biological differences between anti-tumour molecules and NOX4 inhibitors according to their penetration ability.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Medicinal chemistry (Shariqah (United Arab Emirates)) - 8(2012), 2 vom: 28. März, Seite 174-81 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Borbély, Gábor [VerfasserIn] |
---|
Themen: |
EC 1.6.3.- |
---|
Anmerkungen: |
Date Completed 05.11.2012 Date Revised 21.10.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM215896491 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM215896491 | ||
003 | DE-627 | ||
005 | 20231224030510.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2012 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0719.xml |
035 | |a (DE-627)NLM215896491 | ||
035 | |a (NLM)22385185 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Borbély, Gábor |e verfasserin |4 aut | |
245 | 1 | 0 | |a Optimization of important early ADME(T) parameters of NADPH oxidase-4 inhibitor molecules |
264 | 1 | |c 2012 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.11.2012 | ||
500 | |a Date Revised 21.10.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Through their reactive oxygen species (ROS) producing function, NADPH oxidase (NOX) enzymes have been linked to several oxidative stress related diseases. In our recently published paper [1] we have already shown the NOX4 inhibitory effect of diverse, molecule sub-libraries and their biological importance. We also presented our work connected to potential anti-tumour molecules and the relationship between their biological activity and physico-chemical properties [2]. As an extension of these studies further physico-chemical and biological investigation has been carried out on a molecule group included NOX4 inhibitory chromanone compounds. Here we describe the optimization of early ADME(T) parameters determining lipophilicity, phospholipophilicity and permeability linked to structure-activity relationship. We prove that optimal lipo- and phospholipophilicty can be also determined in case of NOX4 inhibitors and a comparison will be made between the chemically similar isochromanone and chromanone molecular libraries. It will be also shown how to predict the effect of different substituents on permeability, lipo- and phospholipophilicity and also the biological differences between anti-tumour molecules and NOX4 inhibitors according to their penetration ability | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Enzyme Inhibitors |2 NLM | |
650 | 7 | |a NADPH Oxidase 4 |2 NLM | |
650 | 7 | |a EC 1.6.3.- |2 NLM | |
650 | 7 | |a NADPH Oxidases |2 NLM | |
650 | 7 | |a EC 1.6.3.- |2 NLM | |
650 | 7 | |a NOX4 protein, human |2 NLM | |
650 | 7 | |a EC 1.6.3.- |2 NLM | |
700 | 1 | |a Huszár, Ménika |e verfasserin |4 aut | |
700 | 1 | |a Varga, Attila |e verfasserin |4 aut | |
700 | 1 | |a Futosi, Krisztina |e verfasserin |4 aut | |
700 | 1 | |a Mócsai, Attila |e verfasserin |4 aut | |
700 | 1 | |a Orfi, László |e verfasserin |4 aut | |
700 | 1 | |a Idei, Miklós |e verfasserin |4 aut | |
700 | 1 | |a Mandl, József |e verfasserin |4 aut | |
700 | 1 | |a Kéri, György |e verfasserin |4 aut | |
700 | 1 | |a Vántus, Tibor |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicinal chemistry (Shariqah (United Arab Emirates)) |d 2005 |g 8(2012), 2 vom: 28. März, Seite 174-81 |w (DE-627)NLM163628467 |x 1875-6638 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2012 |g number:2 |g day:28 |g month:03 |g pages:174-81 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2012 |e 2 |b 28 |c 03 |h 174-81 |